Methadone Maintenance Treatment is under attack in West Virginia

National Alliance of Methadone Advocates
Virginia NAMA
Addiction Treatment Watchdog
Advocates for Recovery through Medicine
Date: January 28, 2004
For Immediate Release

Contact: Joycelyn Woods [email protected]
Charles Kitts [email protected]
Phone: (212) 595-6262
Terri Martinez [email protected]
Chris Kelly [email protected]

Delegate Marshall Long, D-Mercer County, West Virginia, plans to introduce a bill creating new state regulations for Opiate Treatment Programs. Long is eyeing regulations from surrounding states to create another needless layer of regulation.

Because Opiate Treatment Programs in West Virginia comply with best treatment practices outlined in the Federal Regulations and CSAT Accreditation Guidelines, patients enrolled in West Virginia Opiate Treatment Programs currently receive some of the best quality treatment available in the United States. This will change soon if Long has his way.

If Longs proposed bill is passed and regulations such as some of the surrounding states currently have are put into effect, West Virginia patients will no longer be able to access quality treatment. The result could be once stable residents relapsing to active opiate misuse.

Delegate Long has also indicated that West Virginia’s nonprofit mental health centers should run the clinics instead of privately-owned treatment programs. Long said, “We have trouble funding our mental health centers … What better way to fund them?”

This comes at a time when most states are changing their regulations to reflect Opiate Treatment Program Federal Regulations that went into effect May 2001. The regulations and best treatment practices outlined in the CSAT Accreditation Guidelines were written by the top experts in the field of opiate addiction treatment to bring uniformity and quality treatment to Opiate Treatment Programs across the country.

West Virginia doesn’t need another tier of rules and regulations created by politicians to complicate an already over-regulated medical treatment. We hope to educate West Virginia’s elected officials with facts about Methadone Maintenance Treatment, so they can make an educated vote, instead of one based on methadone myths, misinformation and hysteria.

Join us in saving quality medication-assisted treatment for West Virginia patients, and put a stop to this unnecessary waste of taxpayer dollars and elected official’s time by writing West Virginia officials and others.

More information can be obtained at:

Addiction Treatment Watchdog

PO Box 585
Springfield, MO 65801

[email protected]
http://www.atwatchdog.org

Advocates for Recovery through Medicine

PO Box 26377
Washington, DC 20001
[email protected]
http://www.arm-advocates.org

National Alliance of Methadone Advocates (NAMA)
435 Second Avenue
New York, NY 10010
Phone/Fax: (212) 595-NAMA/6262
[email protected]
https://www.methadone.org

Virginia NAMA
[email protected]

Example Letter


West Virginia Legislature Directory


West Virginia Media

News Articles

Charleston Gazette (WV), January 22, 2004.

Methadone Clinics Put On Hold
.

Charleston Daily Mail (WV), January 22, 2004.

Methadone Clinics Forced To Wait
.

Bluefield Daily Telegraph (WV), January 9, 2004.

Moratorium Could Stall Methadone Clinic Project
.

Charleston Gazette (WV), January 8, 2004.

Methadone Clinic Moratorium Possible
.

Clarksburg Exponent, January 24, 2004.

Delegates react to methadone ban proposal
.

Bluefield Daily Telegraph (WV), January, 5, 2004.

LTE- Half Truths About Methadone Clinics
.

Similar Posts

  • The National Methadone Conference-5

    Admin 12/15/2022

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Workshop April 15, 2003 Medication – Assisted Treatment in Different Practice Settings: Patients’ Perspectives Joycelyn Woods, National Alliance of Methadone Advocates, Facilitator NAMA representativees will discuss the administration of methadone in a variety of settings. Topics will include the patients’…

  • FOR IMMEDIATE RELEASE

    Admin 01/30/2022

    October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…

  • Answer one

    Admin 12/31/2022

    FALSE! Current research shows that doses below 60 mg/day are “not effective and hence not appropriate” and that low dose policies for pregnant and non-pregnant patients are associated with increased drug use as well as reduced program retention. Medical withdrawal of opioid dependent women is not recommended in pregnancy because of increased risk to the…

  • In Memory of Ira Sobel

    Admin 03/26/2022

    New York City Many of you may not know who Ira was but to those who knew him from his writings and articles that appeared in many of our affiliates newsletters he was special. In many ways he was the typical patient who had been “hood winked” by the misinformation and negative barrage about methadone….

  • National Alliance for Medication Assisted Recovery

    Admin 09/27/2021

    National Alliance for Medication Assisted Recovery CONFIDENTIAL Grievance/Compliment Report All information that is provided will be held strictly confidential in the same manner as the patient protections described in the U.S. Federal Confidentiality Regulations 42 CFR and the Standards for Privacy of Individually Identifiable Health Information (the Privacy Rule) as established by the Department of…